Evidence map›Paper›PMID 30867221›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2019

Lack of Association between Human Papillomavirus Types 6 and 11 Genetic Variants and Cervical Abnormalities: The Ludwig-McGill Cohort Study.

Laura Sichero, Mariam El-Zein, Silvaneide Ferreira, Eduardo L Franco, Luisa L Villa, Ludwig-McGill Cohort Study

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Laura SicheroCenter for Translational Investigation in Oncology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil. laura.sichero@hc.fm.usp.br.
Mariam El-ZeinDivision of Cancer Epidemiology, McGill University, Montreal, Canada.
Silvaneide FerreiraCenter for Translational Investigation in Oncology, Instituto do Cancer do Estado de Sao Paulo, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil.
Eduardo L FrancoDivision of Cancer Epidemiology, McGill University, Montreal, Canada.ORCID 0000-0002-4409-8084
Luisa L Villa
Ludwig-McGill Cohort Study
Instituto do Câncer do Estado de São Paulo · BRMcGill University · CAUniversidade de São Paulo · BR

Funding

MOLECULAR EPIDEMIOLOGY OF PERSISTENT HPV INFECTIONR01CA070269 · NCI · MCGILL UNIVERSITY · PI FRANCO, EDUARDO L. · 1996 to 2003
$793k
CIHR CRN-83320CIHR MA-13647CIHR MOP-49396NCI NIH HHS R01 CA070269
6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV) types 6 and 11 are mainly associated with the development of genital warts and recurrent respiratory papillomatosis. We examined intratypic genetic variability of both viral types with the development of cervical cytologic abnormalities in Brazilian women.

methodsWe used PCR sequencing to characterize variants of HPVs 6 and/or 11 in cervical swabs from women in the Ludwig-McGill Cohort Study. We used a binomial generalized estimating equations (GEE) model with logit link to estimate odds ratios (OR) and 95% confidence intervals (CI) for the associations between HPV 6 and 11 variants and cytologic abnormalities.

resultsB1 and B3 HPV6 and A2 HPV11 variants were the most common isolates identified. Compared with HPV6-negative women, the ORs among women harboring HPV6 B1 or B3 variants were 6.3 (95% CI, 2.3-17.0) and 2.3 (95% CI, 0.6-9.7) for atypical cells of undetermined significance (ASCUS)/low squamous intraepithelial lesions (LSIL), respectively, and 1.7 (95% CI, 0.6-5.1) and 1.2 (95% CI, 0.3-4.7) for ASCUS/LSIL/high squamous intraepithelial lesions (HSIL). Respective ORs were 5.0 (95% CI, 1.7-14.6) and 2.8 (95% CI, 1.0-8.1) upon comparing women with HPV11 A2 variants to HPV11-negative women. All associations disappeared when adjusting for coinfections with high-risk HPV types.

conclusionsOur data do not support an association between low-risk HPVs 6 and 11 genetic variability and cervical abnormalities. IMPACT: Risk of cervical cytologic abnormalities is not affected by intratypic polymorphism in HPVs 6 and 11.

Indexed as

AdolescentAdultCarcinoma, Squamous CellCohort StudiesDNA, ViralFemaleFollow-Up StudiesGenetic VariationHuman papillomavirus 11Human papillomavirus 6HumansMiddle AgedPapillomavirus InfectionsPrognosisRespiratory Tract InfectionsUterine Cervical DysplasiaDNA, Viral

Identifiers

PMID30867221
PMCPMC6548638
OpenAlexW2922258334

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.